LncRNA TTN-AS1 Promotes Progression of Non-Small Cell Lung Cancer via Regulating miR-491-5p/ZNF503 Axis

References

• Seijo LM, Peled N, Ajona D, et al. Biomarkers in lung cancer screening: achievements, promises, and challenges. J Thorac Oncol. 2019;14(3):343–357. doi:10.1016/j.jtho.2018.11.02330529598
   PubMed Web of Science ®Google Scholar
• Relli V, Trerotola M, Guerra E, Alberti S. Abandoning the notion of non-small cell lung cancer. Trends Mol Med. 2019;25(7):585–594. doi:10.1016/j.molmed.2019.04.01231155338
   PubMed Web of Science ®Google Scholar
• Balata H, Fong KM, Hendriks LE, et al. Prevention and early detection for NSCLC: advances in thoracic oncology 2018. J Thorac Oncol. 2019;14(9):1513–1527. doi:10.1016/j.jtho.2019.06.01131228621
   PubMed Web of Science ®Google Scholar
• Fan C, Tang Y, Wang J, et al. Role of long non-coding RNAs in glucose metabolism in cancer. Mol Cancer. 2017;16(1):130. doi:10.1186/s12943-017-0699-328738810
   PubMedGoogle Scholar
• Lin C, Yang L. Long noncoding RNA in cancer: wiring signaling circuitry. Trends Cell Biol. 2018;28(4):287–301. doi:10.1016/j.tcb.2017.11.00829274663
   PubMed Web of Science ®Google Scholar
• Tong W, Han TC, Wang W, Zhao J. LncRNA CASC11 promotes the development of lung cancer through targeting microRNA-302/CDK1 axis. Eur Rev Med Pharmacol Sci. 2019;23(15):6539–6547. doi:10.26355/eurrev_201908_1853931378894
   PubMed Web of Science ®Google Scholar
• Cui TJ, Lin GS, Dai YM, et al. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer. Eur Rev Med Pharmacol Sci. 2019;23(3Suppl):264–273. doi:10.26355/eurrev_201908_1865631389597
   PubMedGoogle Scholar
• Chen P, Wang R, Yue Q, Hao M. Long non-coding RNA TTN-AS1 promotes cell growth and metastasis in cervical cancer via miR-573/E2F3. Biochem Biophys Res Commun. 2018;503(4):2956–2962. doi:10.1016/j.bbrc.2018.08.07730135013
   PubMed Web of Science ®Google Scholar
• Cui Z, Luo Z, Lin Z, Shi L, Hong Y, Yan C. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis. J Gene Med. 2019;21(5):e3083. doi:10.1002/jgm.308330811764
   PubMed Web of Science ®Google Scholar
• Zhong Y, Wang J, Lv W, Xu J, Mei S, Shan A. LncRNA TTN-AS1 drives invasion and migration of lung adenocarcinoma cells via modulation of miR-4677-3p/ZEB1 axis. J Cell Biochem. 2019;120(10):17131–17141. doi:10.1002/jcb.2897331173403
   PubMed Web of Science ®Google Scholar
• Wu KL, Tsai YM, Lien CT, Kuo PL, Hung AJ. The roles of MicroRNA in lung cancer. Int J Mol Sci. 2019;20:7. doi:10.3390/ijms20071611
   Web of Science ®Google Scholar
• Si W, Shen J, Zheng H, Fan W. The role and mechanisms of action of microRNAs in cancer drug resistance. Clin Epigenetics. 2019;11(1):25. doi:10.1186/s13148-018-0587-830744689
   PubMedGoogle Scholar
• Li Y, Wang D, Li X, et al. MiR-199a-5p suppresses non-small cell lung cancer via targeting MAP3K11. J Cancer. 2019;10(11):2472–2479. doi:10.7150/jca.2942631258753
   PubMed Web of Science ®Google Scholar
• Kang X, Kong F, Wu S, et al. microRNA-612 suppresses the malignant development of non-small-cell lung cancer by directly targeting bromodomain-containing protein 4. Onco Targets Ther. 2019;12:4167–4179. doi:10.2147/OTT.S20400431213835
   PubMed Web of Science ®Google Scholar
• Lu L, Cai M, Peng M, Wang F, Zhai X. miR-491-5p functions as a tumor suppressor by targeting IGF2 in colorectal cancer. Cancer Manag Res. 2019;11:1805–1816. doi:10.2147/CMAR.S18308530863186
   PubMed Web of Science ®Google Scholar
• Chen T, Li Y, Cao W, Liu Y. miR-491-5p inhibits osteosarcoma cell proliferation by targeting PKM2. Oncol Lett. 2018;16(5):6472–6478. doi:10.3892/ol.2018.945130405785
   PubMed Web of Science ®Google Scholar
• Yu T, Wang LN, Li W, et al. Downregulation of miR-491-5p promotes gastric cancer metastasis by regulating SNAIL and FGFR4. Cancer Sci. 2018;109(5):1393–1403. doi:10.1111/cas.1358329569792
   PubMed Web of Science ®Google Scholar
• Gong F, Ren P, Zhang Y, Jiang J, Zhang H. MicroRNAs-491-5p suppresses cell proliferation and invasion by inhibiting IGF2BP1 in non-small cell lung cancer. Am J Transl Res. 2016;8(2):485–495.27158341
   PubMed Web of Science ®Google Scholar
• Yin G, Liu Z, Wang Y, et al. ZNF503 accelerates aggressiveness of hepatocellular carcinoma cells by down-regulation of GATA3 expression and regulated by microRNA-495. Am J Transl Res. 2019;11(6):3426–3437.31312355
   PubMed Web of Science ®Google Scholar
• Jiang C, Li X, Zhao H, Liu H. Long non-coding RNAs: potential new biomarkers for predicting tumor invasion and metastasis. Mol Cancer. 2016;15(1):62. doi:10.1186/s12943-016-0545-z27686732
   PubMed Web of Science ®Google Scholar
• Qu CX, Shi XC, Zai LQ, Bi H, Yang Q. LncRNA CASC19 promotes the proliferation, migration and invasion of non-small cell lung carcinoma via regulating miRNA-130b-3p. Eur Rev Med Pharmacol Sci. 2019;23(3 Suppl):247–255. doi:10.26355/eurrev_201908_1865431389608
   PubMed Web of Science ®Google Scholar
• Ge HB, Chen S, Huang SR, Zhu J. Long noncoding RNA ZFAS1 acts as an oncogene by targeting miR-193a-3p in human non-small cell lung cancer. Eur Rev Med Pharmacol Sci. 2019;23(15):6516–6523. doi:10.26355/eurrev_201908_1853531378891
   PubMed Web of Science ®Google Scholar
• Dong MM, Peng SJ, Yuan YN, Luo HP. LncRNA TTN-AS1 contributes to gastric cancer progression by acting as a competing endogenous RNA of miR-376b-3p. Neoplasma. 2019;66(4):564–575. doi:10.4149/neo_2018_180927N72130943745
   PubMed Web of Science ®Google Scholar
• Jia Y, Duan Y, Liu T, et al. LncRNA TTN-AS1 promotes migration, invasion, and epithelial mesenchymal transition of lung adenocarcinoma via sponging miR-142-5p to regulate CDK5. Cell Death Dis. 2019;10(8):573. doi:10.1038/s41419-019-1811-y31363080
   PubMed Web of Science ®Google Scholar
• Luo J, Liu Z. Long non-coding RNA TTN-AS1 promotes the progression of lung adenocarcinoma by regulating PTEN/PI3K/AKT signaling pathway. Biochem Biophys Res Commun. 2019;514(1):140–147. doi:10.1016/j.bbrc.2019.04.05031027732
   PubMed Web of Science ®Google Scholar
• Chan JJ, Tay Y. Noncoding RNA:RNA regulatory networks in cancer. Int J Mol Sci. 2018;19(5):5. doi:10.3390/ijms19051310
   Web of Science ®Google Scholar
• Takahashi RU, Prieto-Vila M, Kohama I, Ochiya T. Development of miRNA-based therapeutic approaches for cancer patients. Cancer Sci. 2019;110(4):1140–1147. doi:10.1111/cas.1396530729639
   PubMed Web of Science ®Google Scholar
• Zhang J, Ren J, Hao S, et al. MiRNA-491-5p inhibits cell proliferation, invasion and migration via targeting JMJD2B and serves as a potential biomarker in gastric cancer. Am J Transl Res. 2018;10(2):525–534.29511447
   PubMed Web of Science ®Google Scholar
• Zhang Q, Li Q, Xu T, Jiang H, Xu LG. miR-491-5p suppresses cell growth and invasion by targeting Notch3 in nasopharyngeal carcinoma. Oncol Rep. 2016;35(6):3541–3547. doi:10.3892/or.2016.471327035429
   PubMed Web of Science ®Google Scholar
• Zhao Q, Zhai YX, Liu HQ, Shi YA, Li XB. MicroRNA-491-5p suppresses cervical cancer cell growth by targeting hTERT. Oncol Rep. 2015;34(2):979–986. doi:10.3892/or.2015.401326034994
   PubMed Web of Science ®Google Scholar
• Shahi P, Slorach EM, Wang CY, et al. The transcriptional repressor ZNF503/Zeppo2 promotes mammary epithelial cell proliferation and enhances cell invasion. J Biol Chem. 2015;290(6):3803–3813. doi:10.1074/jbc.M114.61120225538248
   PubMed Web of Science ®Google Scholar
• Lu G, Zhang Y. MicroRNA-340-5p suppresses non-small cell lung cancer cell growth and metastasis by targeting ZNF503. Cell Mol Biol Lett. 2019;24(1):34. doi:10.1186/s11658-019-0161-131160893
   PubMed Web of Science ®Google Scholar